Literature DB >> 11956190

Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and CrkII.

Akira Endo1, Ken-Ichiro Nagashima, Hitoshi Kurose, Seibu Mochizuki, Michiyuki Matsuda, Naoki Mochizuki.   

Abstract

Sphingosine 1-phosphate (S1P), a ligand for endothelial differentiation gene family proteins, is one of the most potent signal mediators released from activated platelets. Here, we report that S1P induces membrane ruffling of human umbilical vein endothelial cells (HUVECs) via the vascular endothelial growth factor receptor (VEGFR), Src family tyrosine kinase(s), and the CrkII adaptor protein. S1P induced prominent phosphorylation of CrkII in HUVECs, indicating that CrkII was involved in the S1P-induced signaling pathway. S1P-induced CrkII phosphorylation was blocked by pertussis toxin and overexpression of the carboxyl terminus of beta-adrenergic receptor kinase, indicating that the betagamma subunit of G(i) was required for the phosphorylation. Notably, the S1P-induced CrkII phosphorylation was also abolished by inhibitors of VEGFR or Src family tyrosine kinases. By using Picchu, a real time monitoring protein for CrkII phosphorylation, we found that S1P induced rapid CrkII phosphorylation at membrane ruffles. Finally, we observed that expression of a dominant negative mutant of CrkII inhibited the S1P-induced membrane ruffling and cell migration. These results delineated a novel S1P signaling pathway that involves sequential activation of G(i)-coupled receptor(s), VEGFR, Src family tyrosine kinase(s), and the CrkII adaptor protein, and which is responsible for both the induction of membrane ruffling and the increase in cell motility.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956190     DOI: 10.1074/jbc.M111794200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells.

Authors:  Ken-Ichiro Nagashima; Akira Endo; Hisakazu Ogita; Akiko Kawana; Akiko Yamagishi; Akira Kitabatake; Michiyuki Matsuda; Naoki Mochizuki
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

2.  Differential regulation of pulmonary endothelial monolayer integrity by varying degrees of cyclic stretch.

Authors:  Anna A Birukova; Santipongse Chatchavalvanich; Alexander Rios; Kamon Kawkitinarong; Joe G N Garcia; Konstantin G Birukov
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

3.  Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor.

Authors:  S M Dudek; S M Camp; E T Chiang; P A Singleton; P V Usatyuk; Y Zhao; V Natarajan; J G N Garcia
Journal:  Cell Signal       Date:  2007-04-06       Impact factor: 4.315

4.  Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases.

Authors:  Lynn W Maines; Kevin J French; Ellen B Wolpert; David A Antonetti; Charles D Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

Review 5.  Sphingosine-1-phosphate and modulation of vascular tone.

Authors:  Junsuke Igarashi; Thomas Michel
Journal:  Cardiovasc Res       Date:  2009-02-20       Impact factor: 10.787

Review 6.  Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling.

Authors:  Deborah A Lebman; Sarah Spiegel
Journal:  J Lipid Res       Date:  2008-04-02       Impact factor: 5.922

7.  Endothelial cell migration on RGD-peptide-containing PEG hydrogels in the presence of sphingosine 1-phosphate.

Authors:  Bradley K Wacker; Shannon K Alford; Evan A Scott; Meghna Das Thakur; Gregory D Longmore; Donald L Elbert
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

8.  Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization.

Authors:  Bing Xie; Jikui Shen; Aling Dong; Aymen Rashid; Glenn Stoller; Peter A Campochiaro
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

Review 9.  Targeting SphK1 as a new strategy against cancer.

Authors:  Dai Shida; Kazuaki Takabe; Dmitri Kapitonov; Sheldon Milstien; Sarah Spiegel
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

10.  Crk and CrkL adaptor proteins: networks for physiological and pathological signaling.

Authors:  Raymond B Birge; Charalampos Kalodimos; Fuyuhiko Inagaki; Shinya Tanaka
Journal:  Cell Commun Signal       Date:  2009-05-10       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.